In our study, post-treatment of CDNF also inhibited the formation of leukotoxins (cis and trans 12(13)-EpOME) by CYP450 (Figure S8); thus, in future CDNF could be used as a potential therapy to enhance resilience to stroke-induced pneumonia. This evidence concerns the gene CDNF and pneumonia.